DIFFERENTIAL STIMULATION OF PROTEIN-KINASE-C ACTIVITY BY PHORBOL ESTER OR CALCIUM PHOSPHATIDYLSERINE INVITRO AND IN INTACT SYNAPTOSOMES

被引:0
|
作者
ROBINSON, PJ
机构
[1] Endocrine Unit, John Hunter Hospital, Hunter Region Mail Centre, Locked Bag 1, NSW 2310, Australia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of protein kinase C (PKC) by phorbol 12-myristate 13-acetate (PMA) was compared with calcium/phosphatidylserine (Ca/PS). The substrate specificity of PKC was more limited with PS/PMA. Substrates could be divided into three overlapping groups according to their relative level of phosphorylation: C1, relatively preferred substrates with Ca/PS, included dephosphin, histone, and peptide GS1-10. C2, relatively preferred with PS/PMA, included myelin basic protein and MARCKS. C3, substrates independent of activators. PS/PMA altered the V(max) of PKC for substrate, and decreased the K(m) for Mg2+. Differential substrate phosphorylation by PS/PMA also occurred for PKC isozymes resolved by hydroxylapatite chromatography and was most dramatic for PKC-alpha, which could no longer phosphorylate histone or GS1-12. Differential activities of PKC were also observed in synaptosol and in intact synaptosomes where PMA stimulated phosphorylation of MARCKS, but not dephosphin. It was further shown that dephosphin was indeed a substrate of PKC in the intact synaptosomes by use of a repolarization-dependent dephosphin phosphorylation assay. The differential PKC activities could also be distinguished by inhibitors. H-7 was equipotent, palmitoylcarnitine did not inhibit in vitro C2 phosphorylation, but inhibited dephosphin in intact synaptosomes, and sphingosine did not inhibit Cl substrates and was without effect on dephosphin in intact synaptosomes. Therefore PS/PMA alters or limits the substrate specificity of PKC, leading to a differential substrate phosphorylation in vitro and in intact synaptosomes and differential inhibitor sensitivity. The pattern of protein phosphorylation observed after PKC activation in intact cells will therefore be dependent upon the activator.
引用
收藏
页码:21637 / 21644
页数:8
相关论文
共 50 条
  • [1] SUBSTITUTION BY FATTY-ACIDS FOR PHOSPHATIDYLSERINE IN A RECONSTITUTION OF PHORBOL ESTER BINDING TO PROTEIN-KINASE-C
    IRITA, K
    CUATRECASAS, P
    HEBDON, GM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1991, 23 (7-8): : 755 - 759
  • [2] THE REGULATORY DOMAIN OF PROTEIN-KINASE-C BETA-1 CONTAINS PHOSPHATIDYLSERINE AND PHORBOL ESTER-DEPENDENT CALCIUM-BINDING ACTIVITY
    LUO, JH
    KAHN, S
    ODRISCOLL, K
    WEINSTEIN, IB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (05) : 3715 - 3719
  • [3] APPARENT CALCIUM-INDEPENDENT PHORBOL ESTER BINDING TO PROTEIN-KINASE-C
    GATTI, A
    WATSUJI, T
    HANLEY, M
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : S150 - S150
  • [4] PROTEIN-KINASE-C NEGATIVELY MODULATED BY PHORBOL ESTER
    INAGAKI, M
    HAGIWARA, M
    SAITOH, M
    HIDAKA, H
    FEBS LETTERS, 1986, 202 (02) : 277 - 281
  • [5] PHOSPHORYLATION OF THE PHORBOL ESTER RECEPTOR PROTEIN-KINASE-C
    ASHENDEL, CL
    HERMSEN, L
    MINOR, PL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 191 - 191
  • [6] THE PHORBOL ESTER TPA MARKEDLY ENHANCES THE BINDING OF CALCIUM TO THE REGULATORY DOMAIN OF PROTEIN-KINASE-C BETA-1 IN THE PRESENCE OF PHOSPHATIDYLSERINE
    LUO, JH
    XING, WQ
    WEINSTEIN, IB
    CARCINOGENESIS, 1995, 16 (04) : 897 - 905
  • [7] PROTEIN-KINASE-C AS THE RECEPTOR FOR THE PHORBOL ESTER TUMOR PROMOTERS
    BLUMBERG, PM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 466 - 466
  • [8] PHORBOL ESTER INDUCED DEGRADATION OF IMMUNOPRECIPITABLE PROTEIN-KINASE-C
    BALLESTER, R
    ROSEN, OM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 126 - 126
  • [9] CHARACTERIZATION OF PHORBOL ESTER BINDING TO PROTEIN-KINASE-C ISOTYPES
    DIMITRIJEVIC, SM
    RYVES, WJ
    PARKER, PJ
    EVANS, FJ
    MOLECULAR PHARMACOLOGY, 1995, 48 (02) : 259 - 267
  • [10] DOWN-REGULATION OF PROTEIN-KINASE-C BY PHORBOL ESTER
    INAGAKI, M
    HAGIWARA, M
    SAITOH, M
    HIDAKA, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P105 - P105